Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Cartesian's Descartes-08 Shows Durable Responses In Myasthenia Gravis

(RTTNews) - Tuesday, Cartesian Therapeutics (RNAC) reported additional retreatment data for investigational CAR-T therapy Descartes-08 showing sustained improvements in patients with generalized myasthenia gravis (MG).

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 29 September →